Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR
暂无分享,去创建一个
Scott H. Randell | S. Randell | K. Malcolm | J. Nick | M. Vasil | J. Burns | S. Moskowitz | R. Young | J. Kret | S. Cáceres | K. Poch | D. Nichols | J. Taylor-Cousar | M. Saavedra | Samuel M. Moskowitz | Michael L. Vasil | Robert L. Young | Kenneth C. Malcolm | Jennifer E. Kret | Silvia M. Caceres | Katie R. Poch | David P. Nichols | Jennifer L. Taylor-Cousar | Milene T. Saavedra | Jane L. Burns | Jerry A. Nick | S. Caceres | Jennifer L. Taylor‐Cousar | Milene T Saavedra | Katie Poch
[1] N. McElvaney,et al. The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell , 2011, Archivum Immunologiae et Therapiae Experimentalis.
[2] N. Lanson,et al. RNA interference against CFTR affects HL60-derived neutrophil microbicidal function. , 2010, Free radical biology & medicine.
[3] C. Garlanda,et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps , 2007, The Journal of experimental medicine.
[4] V. Wahn,et al. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. , 2011, Blood.
[5] D. Zurakowski,et al. Pulmonary Outcome in Cystic Fibrosis Is Influenced Primarily by Mucoid Pseudomonas aeruginosa Infection and Immune Status and Only Modestly by Genotype , 1999, Infection and Immunity.
[6] K. Malcolm,et al. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy , 2009, Journal of medical microbiology.
[7] A. O'donnell,et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. , 1998, Chest.
[8] Ramy K. Aziz,et al. DNase Expression Allows the Pathogen Group A Streptococcus to Escape Killing in Neutrophil Extracellular Traps , 2006, Current Biology.
[9] R. Henry,et al. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.
[10] V. Nizet,et al. M1 Protein Allows Group A Streptococcal Survival in Phagocyte Extracellular Traps through Cathelicidin Inhibition , 2009, Journal of Innate Immunity.
[11] C. Haslett,et al. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. , 1985, The American journal of pathology.
[12] D. Cabral,et al. Mucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages , 1987, Pediatric Research.
[13] A. Zychlinsky,et al. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms , 2006, Cellular microbiology.
[14] J. P. Sy,et al. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. , 2001, The Journal of pediatrics.
[15] S. Lory,et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.
[16] M. Vasil,et al. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. , 1987, The Journal of infectious diseases.
[17] P. Janmey,et al. Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. , 1996, The American journal of pathology.
[18] N. McElvaney,et al. LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline1 , 2009, The Journal of Immunology.
[19] Eric Haugen,et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Rubin. Mucus structure and properties in cystic fibrosis. , 2007, Paediatric respiratory reviews.
[21] R. Parad,et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. , 2004, Pediatrics.
[22] J. Goff,et al. Neutrophil extracellular trap formation by bovine neutrophils is not inhibited by milk. , 2006, Veterinary immunology and immunopathology.
[23] V. Valentine,et al. CFTR‐mediated halide transport in phagosomes of human neutrophils , 2010, Journal of leukocyte biology.
[24] David A. D'Argenio,et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. P. Speert,et al. Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation , 2008, Journal of bacteriology.
[26] D. Foster,et al. Seminal DNase Frees Spermatozoa Entangled in Neutrophil Extracellular Traps , 2005, Biology of reproduction.
[27] M. Kosorok,et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition , 2001, Pediatric pulmonology.
[28] Kristian Fog Nielsen,et al. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. , 2010, Environmental microbiology.
[29] F. Conceição-Silva,et al. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps , 2009, Proceedings of the National Academy of Sciences.
[30] M. Elkins,et al. Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions , 2005, Journal of Clinical Microbiology.
[31] J. Emerson,et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.
[32] C. Nast,et al. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa , 1991, Infection and immunity.
[33] Á. Zorreguieta,et al. Extracellular DNA: A Major Proinflammatory Component of Pseudomonas aeruginosa Biofilms , 2010, The Journal of Immunology.
[34] J. Zieleński,et al. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. , 2005, The Journal of pediatrics.
[35] K. Malcolm,et al. Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils , 2005, Infection and Immunity.
[36] R. Smith,et al. Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes. , 1981, The Journal of laboratory and clinical medicine.
[37] V. Nizet,et al. Fetal calf serum contains heat-stable nucleases that degrade neutrophil extracellular traps. , 2009, Blood.
[38] J. Carlin,et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.
[39] P. Davis,et al. State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? , 2003, Respiratory research.
[40] L. Herzenberg,et al. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs , 2009, Proceedings of the National Academy of Sciences.
[41] George M. Hilliard,et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. , 2002, Advanced drug delivery reviews.
[42] C. Mellis,et al. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis , 1992, Pediatric pulmonology.
[43] B. Holloway. Genetic recombination in Pseudomonas aeruginosa. , 1955, Journal of general microbiology.
[44] A. Zychlinsky,et al. Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.
[45] J. Warner,et al. Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis. , 1994, Thorax.
[46] Arturo Zychlinsky,et al. An Endonuclease Allows Streptococcus pneumoniae to Escape from Neutrophil Extracellular Traps , 2006, Current Biology.
[47] V. Valentine,et al. CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. , 2006, Biochemistry.
[48] V. Deretic,et al. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.
[49] M. Hallett,et al. Reduced iC3b‐mediated phagocytotic capacity of pulmonary neutrophils in cystic fibrosis , 2005, Clinical and experimental immunology.
[50] Adeline R. Whitney,et al. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] S. Miller,et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. , 1999, Science.
[52] A. Cowburn,et al. Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation , 2009, European Respiratory Journal.
[53] R. Dummer,et al. Induction of Genes Mediating Interferon-dependent Extracellular Trap Formation during Neutrophil Differentiation* , 2004, Journal of Biological Chemistry.
[54] G. Lenoir,et al. In Cystic Fibrosis Homozygotes and Heterozygotes, Neutrophil Apoptosis Is Delayed and Modulated by Diamide or Roscovitine: Evidence for an Innate Neutrophil Disturbance , 2010, Journal of Innate Immunity.
[55] N. Høiby,et al. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis , 1997, Pediatric pulmonology.
[56] V. Valentine,et al. The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils , 2008, Journal of leukocyte biology.
[57] M. Vasil,et al. Recombinant DNA approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa. , 1987, Antibiotics and chemotherapy.
[58] S. Normark,et al. Capsule and d‐alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps , 2007, Cellular microbiology.
[59] A. Jesaitis,et al. Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions 1 , 2003, The Journal of Immunology.
[60] Charles A. Johnson,et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. , 2007, The Journal of pediatrics.
[61] P. Sly,et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. , 2009, The Journal of pediatrics.
[62] L. Holmberg,et al. Predictors of deterioration of lung function in cystic fibrosis * , 2002, Pediatric pulmonology.
[63] C. Lowell,et al. Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection. , 2009, Blood.
[64] A. Oliver,et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.
[65] J. Emerson,et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.
[66] Stephen R. Clark,et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.
[67] S. Grinstein,et al. Abnormalities in the pulmonary innate immune system in cystic fibrosis. , 2006, American journal of respiratory cell and molecular biology.
[68] R. van Furth,et al. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. , 1979, Immunology.
[69] L. Herzenberg,et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways , 2008, Proceedings of the National Academy of Sciences.
[70] Abdul Hakkim,et al. Restoration of NET formation by gene therapy in CGD controls aspergillosis. , 2009, Blood.
[71] J. Cavaillon,et al. Neutrophils in Cystic Fibrosis Display a Distinct Gene Expression Pattern , 2008, Molecular medicine.
[72] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[73] A. Pollard,et al. Two distinct receptors mediate nonopsonic phagocytosis of different strains of Pseudomonas aeruginosa. , 2001, The Journal of infectious diseases.
[74] G L Johnson,et al. Tumor necrosis factor-alpha activation of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis. , 2001, The Journal of biological chemistry.
[75] H. Simon,et al. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps , 2009, Cell Death and Differentiation.
[76] H. Fuchs,et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. , 1994, The New England journal of medicine.
[77] Abdul Hakkim,et al. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps , 2010, The Journal of cell biology.
[78] S. Lewenza,et al. Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source. , 2010, Environmental microbiology.
[79] D. Riches,et al. Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.
[80] J. G. Hirsch. BACTERICIDAL ACTION OF HISTONE , 1958, The Journal of experimental medicine.
[81] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[82] M. Surette,et al. A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus , 2010, The Journal of Immunology.
[83] Gerald B. Pier,et al. Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.